Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer, Transitional cell cancer
Closed
Phase 2
This trial is looking at combining a chemotherapy drug called eribulin mesylate with gemcitabine and cisplatin chemotherapy. It is for people who have bladder cancer or cancer of the cells lining the urinary tract () that has spread to the nearby tissue () or has spread to another part of the body.
Recruitment start: 9 October 2012
Recruitment end: 20 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen Nicholson
Eisai
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 23 Apr 2014
CRUK internal database number: 7736
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
